粪便免疫化学检测阳性患者结肠镜检查时间与结直肠癌风险
本研究基于2004至2012年台湾全国筛查计划中39,346例粪便免疫化学检测(FIT)阳性且超过1个月完成结肠镜检查的50-69岁患者,分析任何结直肠癌(CRC)及晚期CRC(III-IV期)风险与随访延迟的关系。结果显示,与1-3个月内结肠镜检查相比,延迟超过6个月和超过12个月时任何CRC及晚期CRC风险均显著升高,而3-6个月延迟无显著差异。结论提示FIT阳性后及时结肠镜检查的重要性。
要点
- FIT阳性后结肠镜检查延迟超过6个月,任何CRC风险显著升高(aOR 1.31,95%CI 1.04-1.64)。
- 延迟超过6个月,晚期CRC风险显著升高(aOR 2.09,95%CI 1.43-3.06)。
- 延迟3-6个月与1-3个月相比,任何CRC及晚期CRC风险无显著差异。
核心结论
- FIT阳性患者中,结直肠癌及晚期结直肠癌风险随结肠镜检查延迟时间增加而升高,及时结肠镜检查很重要。
研究设计与样本
- 研究收集2004至2012年台湾全国筛查计划中39,346例50-69岁FIT阳性且超过1个月完成结肠镜检查的患者数据。
- 采用逻辑回归模型评估任何CRC及晚期CRC(III-IV期)风险,结果以调整比值比(aOR)及95%CI表示。
主要发现
- 队列中2,003例诊断为任何CRC,445例为晚期疾病。
- 与1-3个月内结肠镜检查(每1000例患者中任何CRC 50例、晚期疾病11例)相比,延迟超过6个月时任何CRC风险显著升高(aOR 1.31;95%CI 1.04-1.64;每1000例患者68例),晚期疾病风险显著升高(aOR 2.09;95%CI 1.43-3.06;每1000例患者24例)。
- 延迟超过12个月时任何CRC风险进一步升高(aOR 2.17;95%CI 1.44-3.26;每1000例患者98例),晚期疾病风险进一步升高(aOR 2.84;95%CI 1.43-5.64;每1000例患者31例)。
- 3-6个月随访结肠镜检查与1-3个月相比,任何CRC风险无显著差异(aOR 0.98;95%CI 0.86-1.12;每1000例患者49例),晚期疾病风险无显著差异(aOR 0.95;95%CI 0.72-1.25;每1000例患者10例)。
临床怎么用
- 原文结论指出这些发现表明FIT阳性后及时结肠镜检查的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: In patients with positive results from a fecal immunochemical test (FIT), failure to receive a timely follow-up colonoscopy may be associated with higher risks of colorectal cancer (CRC) and advanced-stage CRC. We evaluated the prevalence of any CRC and advanced-stage CRC associated with delays in follow-up colonoscopies for patients with positive results from a FIT. METHODS: We collected data from 39,346 patients (age, 50-69 years) who participated in the Taiwanese Nationwide Screening Program from 2004 through 2012 and had completed a colonoscopy more than 1 month after a positive result from a FIT. Risks of any CRC and advanced-stage CRC (stage III-IV) were evaluated using logistic regression models and results expressed as adjusted odds ratios (aORs) and corresponding 95% CIs. RESULTS: In our cohort, 2003 patients received a diagnosis of any CRC and 445 patients were found to have advanced-stage disease. Compared with colonoscopy within 1-3 months (cases per 1000 patients: 50 for any CRC and 11 for advanced-stage disease), risks were significantly higher when colonoscopy was delayed by more than 6 months for any CRC (aOR, 1.31; 95% CI, 1.04-1.64; 68 cases per 1000 patients) and advanced-stage disease (aOR, 2.09; 95% CI, 1.43-3.06; 24 cases per 1000 patients). The risks continuously increased when colonoscopy was delayed by more than 12 months for any CRC (aOR, 2.17; 95% CI, 1.44-3.26; 98 cases per 1000 patients) and advanced-stage disease (aOR, 2.84; 95% CI, 1.43-5.64; 31 cases per 1000 patients). There were no significant differences for colonoscopy follow up at 3-6 months for risk of any CRC (aOR, 0.98; 95% CI, 0.86-1.12; 49 cases per 1000 patients) or advanced-stage disease (aOR, 0.95; 95% CI, 0.72-1.25; 10 cases per 1000 patients). CONCLUSIONS: In an analysis of data from the Taiwanese Nationwide Screening Program, we found that among patients with positive results from a FIT, risks of CRC and advanced-stage disease increase with time. These findings indicate the importance of timely colonoscopy after a positive result from a FIT.
引用
- Lee YC, Fann JC, Chiang TH, et al. Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests. Clin Gastroenterol Hepatol. 2018. PMID: 30391435. doi:10.1016/j.cgh.2018.10.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。